Literature DB >> 8576634

Ethanol modulates apolipoprotein B mRNA editing in the rat.

P P Lau1, D J Cahill, H J Zhu, L Chan.   

Abstract

We have studied the rat ethanol-liquid diet model for chronic ethanol modulation of lipid homeostasis, apolipoprotein (apo) B production and apoB mRNA editing. Male Wistar rats were fed one of three diets: i) regular chow, ii) an isocaloric liquid diet, or iii) isocaloric ethanol-liquid diet where ethanol accounts for 35.5% of the total calories, for up to 40 days. There was no difference in body weight or liver/body weight ratio among the three groups of animals at the end of the feeding period. Hepatic and plasma triglycerides were elevated in the ethanol-treated animals only, correlated with an accumulation of lipid particles in the liver of these animals. By DNA excess hybridization, the steady state mRNA levels of apoB and apoB mRNA-editing protein relative to actin were not significantly altered. The proportion of edited apoB mRNA; i.e., apoB-48 mRNA/(apoB-48 + B-100) mRNA, increased in a time-dependent manner from approximately 50% to 100% in the ethanol-treated group. It remained unchanged in the chow- and liquid diet-fed animals. The proportion of apoB-48/apoB-100 protein synthesis was determined by [35S]methionine labeling followed by specific immunoprecipitation and SDS-polyacrylamide gel electrophoresis. The amount of newly synthesized apoB-48 increased from 30-50% to > 99% of the total apoB (apoB-48 + apoB-100). This increase in apoB-48 biosynthesis is reflected by an increase in circulating plasma apoB-48 from barely detectable to approximately 50% of total plasma apoB. Fractionation of plasma lipoproteins by fast protein liquid chromatography (FPLC) indicates that the ethanol-induced hypertriglyceridemia is completely accounted for by an increase in plasma very low density lipoprotein (VLDL). The proportion of apoB-48 as a percent of total apoB in the VLDL fraction increased from approximately 50% in controls to > 90% in ethanol-treated animals. Furthermore, there is a strong correlation between plasma triglyceride concentration and proportion of edited apoB-mRNA in the liver of ethanol-treated rats, but no direct correlation of the latter with intrahepatic triglyceride content. Ethanol-treated rats represent a new model for studying the regulation of apoB mRNA editing by dietary factors in vivo.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8576634

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  13 in total

1.  Acute modulation of the extent of apoB mRNA editing and the relative rates of syntheses of apoB48 and apoB100 in cultured rat hepatocytes by osmotic and other stress stimuli.

Authors:  A McCahill; D J Lankester; B S Park; N T Price; V A Zammit
Journal:  Mol Cell Biochem       Date:  2000-05       Impact factor: 3.396

2.  Hepatic very-low-density lipoprotein and apolipoprotein B production are increased following in vivo induction of betaine-homocysteine S-methyltransferase.

Authors:  Janet D Sparks; Heidi L Collins; Doru V Chirieac; Joanne Cianci; Jenny Jokinen; Mark P Sowden; Chad A Galloway; Charles E Sparks
Journal:  Biochem J       Date:  2006-04-15       Impact factor: 3.857

3.  Functional characterization of APOBEC-1 complementation factor phosphorylation sites.

Authors:  David M Lehmann; Chad A Galloway; Celeste MacElrevey; Mark P Sowden; Joseph E Wedekind; Harold C Smith
Journal:  Biochim Biophys Acta       Date:  2006-12-08

4.  Mouse and other rodent models of C to U RNA editing.

Authors:  Valerie Blanc; Nicholas O Davidson
Journal:  Methods Mol Biol       Date:  2011

Review 5.  The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome.

Authors:  Jung Sub Lim; Michele Mietus-Snyder; Annie Valente; Jean-Marc Schwarz; Robert H Lustig
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-04-06       Impact factor: 46.802

6.  Phosphorylation is a regulatory mechanism in apolipoprotein B mRNA editing.

Authors:  Z Chen; T L Eggerman; A P Patterson
Journal:  Biochem J       Date:  2001-08-01       Impact factor: 3.857

7.  Metabolic regulation of APOBEC-1 complementation factor trafficking in mouse models of obesity and its positive correlation with the expression of ApoB protein in hepatocytes.

Authors:  Chad A Galloway; John Ashton; Janet D Sparks; Robert A Mooney; Harold C Smith
Journal:  Biochim Biophys Acta       Date:  2010-06-09

8.  Regulatable liver expression of the rabbit apolipoprotein B mRNA-editing enzyme catalytic polypeptide 1 (APOBEC-1) in mice lacking endogenous APOBEC-1 leads to aberrant hyperediting.

Authors:  Martin Hersberger; Susannah Patarroyo-White; Xiaobing Qian; Kay S Arnold; Lucia Rohrer; Maureen E Balestra; Thomas L Innerarity
Journal:  Biochem J       Date:  2003-01-15       Impact factor: 3.857

9.  The expression of apoB mRNA editing factors is not the sole determinant for the induction of editing in differentiating Caco-2 cells.

Authors:  Chad A Galloway; Harold C Smith
Journal:  Biochem Biophys Res Commun       Date:  2009-11-20       Impact factor: 3.575

10.  Hepatocyte growth factor leads to recovery from alcohol-induced fatty liver in rats.

Authors:  M Tahara; K Matsumoto; T Nukiwa; T Nakamura
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.